J Am Coll Cardiol. 2008, 52:865-868. 2. Healey JS, et al. Global Variations in the 1-12 months Rates of Stroke and Loss of life in 15,340 Patients Presenting to the Emergency Department with Atrial Fibrillation in 47 Countries: The RE-LY AF Registry. Presented at the European Society of Cardiology Congress 2012, august 2012 29th. 3. Healey JS, et al. Global variation in the etiology and management of atrial fibrillation: results from a global atrial fibrillation registry – Presented at the European Society of Cardiology Congress 2011, 2011 August, session number 711006. 4. Lloyd-Jones DM, et al.In November 2008 by Biovail’s advertising partner Ovation Pharmaceuticals, Inc. . These elements had been partially offset by incremental revenues from the way to obtain a certified generic formulation of the 100mg and 200mg dosage strengths.4 million, weighed against $8.9 million for the corresponding period in ’09 2009.0 million, weighed against $17.1 million in the first half of 2009. June 30 The decreases in product sales for the three and half a year finished, 2010 reflect lower prescription volumes because of the introduction of generic competition in March 2010.